BPC-157 For Knee Pain: Early Reported Outcomes A report on intra-articular BPC-157 for knee pain described high rates of improvement: ~92% with BPC-157 alone, ~75% when combined with thymosin beta-4, and overall pain relief reported in 87.5% of patients
Interaction of antiphospholipid antibodies with endothelial cells in antiphospholipid syndrome
Phosphatidylcholine IV Treatments Phosphatidylcholine IV therapy is an effective way to repair the cell membrane and support detoxification
Saeed H, Mantagos IS, Chodosh J
Both have potential for side effects, but if youre eligible for both medications, using them together is unlikely to add extra risk, says Lee
Results may last several days, depending on individual health and lifestyle